Sarepta Therapeutics financials at a glance

+ Portfolio

The revenue of Sarepta Therapeutics is reported as 0.93301 billion Dollars in the fiscal year 2023. The earnings were -3.06 Dollars per share in 2023, which was 19.47 higher than 2021. And about -0.32535 billion Dollars are reported as free cash flow in the financials of Sarepta Therapeutics 2023. No dividends were paid to the shareholders of the Sarepta Therapeutics stock NasdaqGS:SRPT in the financial year 2023.

$933.01M

Revenue

$-3.06

Earnings Per Share

-8.37%

Gross Margin %

$-,356.17M

Free Cash Flow

Revenue

933.01

Earnings Per Share

-3.06

Gross Margin %

-8.37

Free Cash Flow

-,356.17

Financials

Year	Year	TTM	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004
Rev.	Revenue	N/A	$933.01M	$701.89M	$540.10M	$380.83M	$301.03M	$154.58M	$5.42M	$1.25M	$9.76M	$14.22M	$37.33M	$46.99M	$29.42M	$17.59M	$21.26M	$10.99M	$0.12M	$4.78M	$0.43M
GM %	Gross Margin %	7.09%	-8.37%	-23.63%	-45.46%	-62.09%	-43.55%	95.24%	0.00%	0.00%	0.00%	0.00%	-39.12%	-41.23%	100.00%	-38.73%	-28.57%	-,182.73%	0.00%	-,233.58%	0.00%
OM	Operating Margin	-35.59%	-56.83%	-64.00%	-,104.44%	-,137.10%	-,113.59%	-92.25%	0.00%	0.00%	0.00%	0.00%	-78.00%	-74.12%	-71.16%	-88.18%	-82.52%	-,286.65%	0.00%	0.00%	0.00%
EPS	Earnings Per Share	$-7.81	$-3.06	$-3.80	$-5.83	$-4.30	$-2.14	$-1.51	$-3.94	$-4.44	$-3.32	$-2.63	$-5.14	$-0.12	$-1.74	$-1.62	$-2.04	$-3.00	$-3.54	$-2.22	$-4.14
Div.	Dividends	N/A	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
PR %	Payout Ratio %	0	-0.00%	-0.00%	-0.00%	-0.00%	-0.00%	-0.00%	-0.00%	-0.00%	-0.00%	-0.00%	0	0	0	0	0	0	0	-0.00%	0
Sha.	Shares	N/AM	87.98M	87.15M	79.42M	77.78M	71.29M	64.98M	54.81M	45.67M	41.31M	37.78M	31.83M	22.62M	18.76M	18.4M	14.27M	10.8M	8.88M	8.74M	7.36M
OCF	Operating Cash Flow	N/A	$-,325.35M	$-,443.17M	$107.47M	$-,456.46M	$-,388.66M	$-,232.00M	$-,245.82M	$-,149.47M	$-,128.54M	$-64.70M	$0.00M	$-23.68M	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M
FCF	Free Cash Flow	N/A	$-,356.17M	$-,481.66M	$25.26M	$-,516.09M	$-,449.82M	$-,244.00M	$-,251.16M	$-,152.87M	$-,153.98M	$-67.07M	$0.00M	$-24.86M	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M
FCFS	Free Cash Flow Per Share	$-5.79	$-4.07	$-4.67	$1.71	$-7.05	$-6.84	$-2.18	$-5.19	$-3.65	$-3.88	$-2.02	$-1.31	$-1.20	$-0.93	$-0.70	$-1.17	$-2.98	$-2.51	$-2.17	$-4.22

Sarepta Therapeutics financials at a glance

Financials

Discover